← Back to Patent Explorer
US4508709A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for purifying factor VIII:C

Assignee: Armour Pharmaceutical Co
•
Filing: 1983-12-05
•
Granted: 1985-04-02
•
Expires: 2003-12-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Factor VIII:C is purified by chromatographic absorption on aminohexyl agarose at a pH above 5.5 up to about 8, and preferably 6.5 to 7.2, and a conductivity of about 25 to about 35 mS/cm.

Inventors

  • 👤 Godfrey W. Amphlett
  • 👤 Michael E. Hrinda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 04:25
CPC Classifications
C; C07; C07K; C07K1/00; C07K1/14; C07K14/00; C07K14/435; C07K14/745; C07K14/755; A; A61; A61P; A61P7/00; A61K; A61K38/00

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 82 words
A process for purifying Factor VIII:C from source material containing antihemophilic factor, comprising (a) providing an aqueous solution of said source material which has a pH of 6.0 to about 8.0, and a conductivity of about 25 mS/cm to 35 mS/cm, (b) equilibrating aminohexyl agarose to the pH of said solution, (c) adsorbing antihemophilic factor from said solution onto said equilibrated aminohexyl agarose, (d) eluting Factor VIII:R from the aminohexyl agarose, and then (e) eluting the Factor VIII:C from the aminohexyl agarose.
Claim 2
Dependent Claim 82 words
A process for purifying Factor VIII:C from source material containing antihemophilic factor, comprising (a) providing an aqueous solution of said source material which has a pH of 6.0 to about 8.0, and a conductivity of about 25 mS/cm to 35 mS/cm, (b) equilibrating aminohexyl agarose to the pH of said solution, (c) adsorbing antihemophilic factor from said solution onto said equilibrated aminohexyl agarose, (d) eluting Factor VIII:R from the aminohexyl agarose, and then (e) eluting the Factor VIII:C from the aminohexyl agarose.
Claim 3
Dependent Claim 16 words
The process of claim 1 wherein the pH of said source material is 6.0 to 7.5.
Claim 4
Dependent Claim 16 words
The process of claim 1 wherein the pH of said source material is 6.5 to 7.2.
Claim 5
Dependent Claim 20 words
The process of claim 1 wherein the aminohexyl agarose contains at least about 10 micromoles of aminohexyl chains per gram.
Claim 6
Dependent Claim 14 words
The process of claim 1 wherein the source material is plasma which contains AHF.
Claim 7
Dependent Claim 16 words
The process of claim 1 wherein the source material is a plasma concentrate which contains AHF.
Claim 8
Dependent Claim 15 words
The process of claim 1 wherein the source material is a cryoprecipitate which contains AHF.
Claim 9
Dependent Claim 21 words
The process of claim 1 wherein the source material also contains fibronectin, and the fibronectin is eluted with the Factor VIII:R.
Claim 10
Dependent Claim 21 words
The process of claim 1 wherein the source material also contains fibrinogen, and the fibrinogen is eluted with the Factor VIII:R.
Claim 11
Dependent Claim 19 words
The process of claim 1 wherein the Factor VIII:C is purified with a yield of at least about 30%.
Claim 12
Dependent Claim 46 words
The process of claim 1 wherein the Factor VIII:C is purified with a yield of at least about 50%, and wherein a proteolytic inhibitor is present in steps (a), (b), (c) and (d) in a small but effective amount to inhibit proteolysis of the Factor VIII:C.
Claim 13
Dependent Claim 26 words
The process of claim 1 wherein the Factor VIII:C is purified by a factor of at least about 10 times its purity in the source material.
Claim 14
Dependent Claim 26 words
The process of claim 1 wherein the Factor VIII:C is purified by a factor of at least about 20 times its purity in the source material.
Claim 15
Dependent Claim 20 words
The process of claim 1 wherein the Factor VIII:C is eluted with a buffered aqueous solution containing 1.0 M NaCl.
Claim 16
Dependent Claim 24 words
The process of claim 1 wherein the Factor VIII:C is eluted with an aqueous buffered solution containing 0.3 to 0.5 M CaCl 2 .
Claim 17
Dependent Claim 74 words
The process for purifying Factor VIII:C from source material containing antihemophilic factor, comprising (a) providing an aqueous solution of said source material which has a pH of 6.0 to about 8.0 and a conductivity of about 25 mS/cm to 35 mS/cm, (b) equilibrating aminohexyl agarose to the pH of said solution, (c) adsorbing antihemophilic factor from said solution onto said equilibrated aminohexyl agarose, and then (d) eluting the Factor VIII:C from the aminohexyl agarose.
Claim 18
Dependent Claim 74 words
The process for purifying Factor VIII:C from source material containing antihemophilic factor, comprising (a) providing an aqueous solution of said source material which has a pH of 6.0 to about 8.0 and a conductivity of about 25 mS/cm to 35 mS/cm, (b) equilibrating aminohexyl agarose to the pH of said solution, (c) adsorbing antihemophilic factor from said solution onto said equilibrated aminohexyl agarose, and then (d) eluting the Factor VIII:C from the aminohexyl agarose.
Claim 19
Dependent Claim 15 words
The process of claim 16 wherein the source material is plasma which contains antihemophilic factor.
Claim 20
Dependent Claim 17 words
The process of claim 16 wherein the source material is a plasma concentrate which contains antihemophilic factor.
Claim 21
Dependent Claim 16 words
The process of claim 16 wherein the source material is a cryoprecipitate which contains antihemophilic factor.
Claim 22
Dependent Claim 20 words
The process of claim 16 wherein the pH of the aqueous solution provided in step (a) is 6.0 to 7.5.
Claim 23
Dependent Claim 20 words
The process of claim 16 wherein the pH of the aqueous solution provided in step (a) is 6.5 to 7.2.

References Cited (Backward Citations)

US4361509A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-04-01 1988-10-01 1989-04-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-04-01 1992-10-01 1993-04-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-04-01 1996-10-01 1997-04-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag